Russia has the world’s third-highest toll of coronavirus infections after the United States and Brazil, and after almost 50 different vaccine projects, Russia has approved an anti-influenza drug to treat Covid-19 and will start delivering courses of the drug, Avifavir, to hospitals in June. 

Japan on Thursday became the second country, after the US, to authorise the antiviral drug remdesivir to treat coronavirus patients, the governent said, concurently concurently eyeing to approving another medication Avigan this month.